Jointly provided by Postgraduate Institute for Medicine and Novus Medical Education.
This activity has been supported by an independent educational grant from Otsuka America Pharmaceutical, Inc. and Lundbeck.
This Expert Exchange webcast provides learners with real-world application of best practices in the management of patients with bipolar disorder.
This activity has been designed to meet the educational needs of health care professionals involved in the diagnosis, treatment and management of patients with bipolar disorder.
Upon completion of this activity, participants will be better able to do the following:
Joseph F. Goldberg, MD
Clinical Professor of Psychiatry
Icahn School of Medicine at Mt. Sinai
New York, NY
Roger S. McIntyre, MD
Professor of Psychiatry & Pharmacology
University of Toronto
Head, Mood Disorders Psychopharmacology Unit
University Health Network
Toronto, Canada
Chamique S. Holdsclaw
Patient Participant
Rancho Cucamonga, CA
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Novus Medical Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material is approved for 1 year from the date of original release, April 6, 2018 to April 6, 2019.
There are no fees for participating and receiving CME credit for this activity. To claim credit, participants must complete the following:
Estimated Completion Time: 30 minutes
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Roger S. McIntyre, MD
Grant/Research Support: Allergan, Lundbeck, Purdue, Shire
Speakers Bureau/Consulting: Allergan, Janssen-Ortho, Lundbeck, Neuralstem,
Neurocrine, Otsuka, Pfizer, Purdue, Shire, Sunovion,
Takeda
Joseph F. Goldberg, MD
Advisory Board/Consulting/Speakers Bureau: Neurocrine, Otsuka, Sunovion
Speakers Bureau: Lundbeck, Merck, Takeda
Chamique S. Holdsclaw
Nothing to disclose.
Planners and Managers
The PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD,
CHCP, Judi Smelker-Mitchek, MBA, MSN, RN, and Jan Schultz, MSN, RN, CHCP have nothing to
disclose. The Novus Medical Education planner/manager, Steven Scrivner, MPA, CHCP, has
nothing to disclose.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
For all CME certification inquiries, please contact Postgraduate Institute for Medicine at: inquiries@pimed.com or 303-799-1930.